Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Precision treatment in advanced hepatocellular carcinoma
Xupeng Yang, Chen Yang, Shu Zhang, et al.
Cancer Cell (2024) Vol. 42, Iss. 2, pp. 180-197
Open Access | Times Cited: 112

Showing 1-25 of 112 citing articles:

Clinical advances of mRNA vaccines for cancer immunotherapy
Alexey V. Yaremenko, Muhammad Muzamil Khan, Xueyan Zhen, et al.
Med (2025) Vol. 6, Iss. 1, pp. 100562-100562
Closed Access | Times Cited: 4
Development and evaluation of hyaluronic acid-coated chitosan nanoparticles for improved delivery of sorafenib tosylate in the treatment of hepatocellular carcinoma
Putrevu Sreelaya, Sankha Bhattacharya, Darshan Bhirud, et al.
BioNanoScience (2025) Vol. 15, Iss. 1
Closed Access | Times Cited: 2
CD151-enriched migrasomes mediate hepatocellular carcinoma invasion by conditioning cancer cells and promoting angiogenesis
Kangnan Zhang, Zhenhua Zhu, Rongrong Jia, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 11
Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy
Chen Yang, Haigang Geng, Xupeng Yang, et al.
Cancer Cell (2024) Vol. 42, Iss. 12, pp. 2064-2081.e19
Closed Access | Times Cited: 11
Delivery of natural products via polysaccharide-based nanocarriers for cancer therapy: A review on recent advances and future challenges
Yingjie Jiang, Chunmei Yan, Minghao Li, et al.
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 135072-135072
Closed Access | Times Cited: 10
Proteomic Characterization of Liver Cancer Cells Treated with Clinical Targeted Drugs for Hepatocellular Carcinoma
Hui Long, Jiafu Zhou, Caicun Zhou, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 152-152
Open Access | Times Cited: 1
Formosanin C Induces Autophagy-Mediated Cell Death in Hepatocellular Carcinoma Through Activating DUSP1/AMPK/ULK1/Beclin1 Signaling Pathway
Zhikai Wen, Jinxia Qi, Qingqing Ruan, et al.
Phytomedicine (2025) Vol. 138, pp. 156404-156404
Closed Access | Times Cited: 1
Biomarker discovery in hepatocellular carcinoma (HCC) for personalized treatment and enhanced prognosis
Baofa Yu, Wenxue Ma
Cytokine & Growth Factor Reviews (2024) Vol. 79, pp. 29-38
Closed Access | Times Cited: 7
Immunotherapy in liver cancer: overcoming the tolerogenic liver microenvironment
Yanju Liu, Hongyuan Yang, Tian Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Role of extracellular vesicle-associated proteins in the progression, diagnosis, and treatment of hepatocellular carcinoma
Yao-Ge Liu, Shitao Jiang, Junwei Zhang, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Habitat radiomics based on CT images to predict survival and immune status in hepatocellular carcinoma, a multi-cohort validation study
Kun Chen, Chunxiao Sui, Ziyang Wang, et al.
Translational Oncology (2025) Vol. 52, pp. 102260-102260
Open Access
Rhoifolin Suppresses Cell Proliferation and Induces Apoptosis in Hepatocellular Carcinoma Cells In Vitro and In Vivo
Ruolan Chen, Zufa Sabeel, Ying Lu, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 79-79
Open Access
LARP3 inhibits the apoptosis of hepatocellular carcinoma via the ROS/PI3K/c-Fos axis
Lin Zhu, Qianqian Meng, Weiyi Qian, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0317454-e0317454
Open Access
The expression landscape and clinical significance of methyltransferase-like 17 in human cancer and hepatocellular carcinoma: a pan-cancer analysis using multiple databases
Yezhou Ding, Mingyang Feng, Wanqing Chi, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Cellular Senescence in Hepatocellular Carcinoma: Immune Microenvironment Insights via Machine Learning and In Vitro Experiments
Xinhe Lu, Yuhang Luo, Yun Huang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 773-773
Open Access
Identification of Hepatocellular Carcinoma Subtypes Based on Global Gene Expression Profiling to Predict the Prognosis and Potential Therapeutic Drugs
Cunzhen Zhang, Jiyao Wang, Lin Jia, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 236-236
Open Access
Ribosomal protein L6 suppresses hepatocellular carcinoma by modulating FBXO22-mediated p53 degradation
Zhen Lei, Yiming Luo, Qinggang Fu, et al.
Cellular Signalling (2025) Vol. 127, pp. 111612-111612
Open Access
Targeted delivery of curcumin and CM11 peptide against hepatocellular carcinoma cells based on binding affinity of PreS1-coated chitosan nanoparticles to SB3 protein
Danial Rahmani, Ramezan Ali Taheri, Mehrdad Moosazadeh Moghaddam
Amino Acids (2025) Vol. 57, Iss. 1
Open Access
Optimizing interventional therapy: A homogeneous lipiodol formulation of Tirapazamine and Sorafenib responsive to post-embolization microenvironment
Xing Gao, Hongwei Cheng, Minglei Teng, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 879-889
Closed Access
Lenvatinib and tislelizumab versus atezolizumab and bevacizumab in combination with TAE-HAIC for unresectable hepatocellular carcinoma with high tumor burden: a multicenter retrospective cohort study
Hongjie Cai, Song Chen, Shuang‐Yan Tang, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 3
Open Access
Self-assembling chemodrug fiber-hydrogel for transarterial chemoembolization and radiotherapy-enhanced antitumor immunity
Yisheng Peng, Hui Liu, Xiaoliu Liang, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 1-16
Closed Access
Predicting the early therapeutic response to hepatic artery infusion chemotherapy in patients with unresectable HCC using a contrast-enhanced computed tomography-based habitat radiomics model: a multi-center retrospective study
Mingsong Wu, Zenglong Que, Shujie Lai, et al.
Cellular Oncology (2025)
Open Access
Minimalistic Implant for Percutaneous Magnetic Hyperthermia-Based Combination Therapy of Hepatocellular Carcinoma
Guangchao Xie, Bingjie Li, Shuyue Guo, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
Deubiquitinase USP28 promotes the malignant progression and radio-resistance of hepatocellular carcinoma by stabilizing WDHD1
Wen Wu, Zhenhua Zhou, Chao Chen, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Targeting DUSP3 Promotes Cell Senescence by Activating the Notch1 Pathway to Treat Hepatocellular Carcinoma
Wenjun Zhang, Jun-Lu Peng, Da-Fei Dai, et al.
Tissue and Cell (2025) Vol. 94, pp. 102781-102781
Open Access
Page 1 - Next Page

Scroll to top